| Autor: |
Heuser, Michael, Tschan-Plessl, Astrid, Thol, Felicitas, Schwarzer, Adrian, Kloos, Arnold, Kattre, Nadine, Passweg, Jakob, Pinkernell, Kai, Ganser, Arnold |
| Zdroj: |
Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p1745-1745, 1p |
| Abstrakt: |
Although the majority of patients with acute myeloid leukemia (AML) achieve complete remission (CR), most of them relapse due to measurable residual disease (MRD), leading to poorer prognosis. The elimination of MRD before morphological relapse in patients who achieved CR is therefore an important therapeutic strategy to achieve improved long term outcomes in AML. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
